A.P. Gilfoyle & Co’s Eli Lilly LLY Stock Holding History

A.P. Gilfoyle & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-250	Closed	-$116K	–	12
2023 Q4	$116K	Buy	+250	New	+$146K	21.63%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

A.P. Gilfoyle & Co's LLY Position: Q1 2024 in Review

A.P. Gilfoyle & Co sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 250 shares — an estimated $116K sold.

A.P. Gilfoyle & Co first reported a position in LLY in Q4 2023 and held it in 1 quarter. The position peaked at $116K in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

A.P. Gilfoyle & Co reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
A.P. Gilfoyle & Co sold 250 Eli Lilly shares in Q1 2024, an estimated $116K.
A.P. Gilfoyle & Co first reported a position in Eli Lilly in Q4 2023 and held it in 1 quarter.
A.P. Gilfoyle & Co's Eli Lilly position peaked at $116K in Q4 2023.
3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on A.P. Gilfoyle & Co's 13F filing for Q1 2024, filed 1 Apr 2024.